Categories
Loading...
Categories
Epigral reported record Q4FY26 revenue of ₹736 Cr, up 17% YoY, with PAT jumping 109% QoQ and EBITDA margins at 23%. A ₹5 per share dividend is proposed. Major CPVC and Epichlorohydrin capacity expansions are on track, targeting future growth.